G. Ahsan

发表

Post‐thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes

P. Veys, P. Amrolia, John Anderson, 2016, British journal of haematology.

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Matthew J. Frigault, G. Lucchini, Jackie Chappell, 2020, The Lancet.

Coexistent hairy cell leukaemia and chronic lymphocytic leukaemia.

G. Ahsan, S. Brown, J. Phillips, 1998, Leukemia & lymphoma.

Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation.

A. Gennery, P. Veys, P. Amrolia, 2018, Cytotherapy.

The effects of prior induction therapy with melphalan on subsequent peripheral blood progenitor cell transplantation for myeloma.

G. Ahsan, M. Kazmi, S. Schey, 2001, Clinical and laboratory haematology.

Thalidomide induced remission of refractory diffuse large B-Cell Lymphoma post-allogeneic SCT.

J. Madrigal, G. Ahsan, M. Kazmi, 2006, Haematologica.

Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells

Adrian J. Thrasher, Waseem Qasim, Stuart Adams, 2017, Science Translational Medicine.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

G. Lucchini, A. Hackshaw, P. Veys, 2019, Nature Medicine.

First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL

K. Peggs, P. Veys, S. Samarasinghe, 2015 .

New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies.

A. Gennery, P. Veys, A. Worth, 2019, The Journal of allergy and clinical immunology.

Dose intensification and molecular responses in patients with chronic lymphocytic leukaemia: a phase II single centre study

G. Ahsan, S. Schey, R. Jones, 1999, Bone Marrow Transplantation.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

G. Lucchini, A. Hackshaw, P. Veys, 2019, Nature Medicine.

Haematopoietic Stem Cell Transplantation for DNA Ligase 1 Deficiency

G. Lucchini, P. Jeggo, P. Veys, 2020, Journal of clinical immunology.

Haematopoietic Stem Cell Transplantation for DNA Ligase 1 Deficiency

G. Lucchini, P. Jeggo, P. Veys, 2020, Journal of Clinical Immunology.

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

G. Lucchini, A. Hackshaw, P. Veys, 2019, Blood.